Specialties

Medical Oncology (Board certified since 1997)

Hematology (Board certified since 1997)

Internal Medicine (Board certified since 1995)

At a Glance

  • 1999 Started practicing
  • 18 Years experience
  • 2 OFFICE LOCATIONS
  • 2 HOSPITAL AFFILIATIONS

About Dr. Saba

My Clinical Interests

  • esophageal cancer
  • head & neck cancer
  • lung cancer
  • Medical Oncology
  • thyroid cancer

Academic Profile

Training

MEDICAL SCHOOL

American University Beirut, Beirut, Lebanon

INTERNSHIP

University of Wisconsin Hospital and Clinic, Madison, WI

RESIDENCY

Faulkner Hospital, Boston, MA

FELLOWSHIP

Brown University, Providence, RI

Princess Margaret Hospital, Toronto, ON, Canada

Professional Memberships

American Head and Neck Cancer Society

American College of Radiology (Head and Neck Panel)

American College of Physicians

American Society of Clinical Oncology

Massachusetts Medical Society

Languages spoken

  • Arabic
  • French

Major Publications

Owonikoko TK, Ramalingam SS, Miller DL, Force SD, Sica GL, Mendel J, Chen Z, Rogatko A, Tighiouart M, Harvey RD, Kim S, Saba NF, Pickens A, Behera M, Fu RW, Rossi MR, Auffermann WF, Torres WE, Bechara R, Deng X, Sun SY, Fu H, Gal AA, Khuri FR. A Translational, Pharmacodynamic, and Pharmacokinetic Phase IB Clinical Study of Everolimus in Resectable Non-Small Cell Lung Cancer; Clin Cancer Res. 2015 Apr 15;21(8):1859-68.

Steuer CE, Behera M, Kim S, Patel N, Chen Z, Pillai R, Saba NF, Shin DM, Owonikoko TK, Khuri FR, Ramalingam SS; Predictors and outcomes of venous thromboembolism in hospitalized lung cancer patients: A Nationwide Inpatient Sample database analysis. Lung Cancer. 2015 Apr;88(1):80-4.

Strojan P, Vermorken JB, Beitler JJ, Saba NF, Haigentz M, Bossi P, Worden FP, Langendijk JA, Eisbruch A, Mendenhall WM, Lee AW, Harrison LB, Bradford CR, Smee R, Silver CE, Rinaldo A, Ferlito A; Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic review; Head Neck. 2015 Mar 3.

Haque A, Rahman MA, Chen ZG, Saba NF, Khuri FR, Shin DM, Ruhul Amin AR; Combination of erlotinib and EGCG induces apoptosis of head and neck cancers through posttranscriptional regulation of Bim and Bcl-2; Apoptosis. 2015 Apr 10.

Joseph LJ, Goodman M, Higgins K, Pilai R, Ramalingam SS, Magliocca K, Patel MR, El-Deiry M, Wadsworth JT, Owonikoko TK, Beitler JJ, Khuri FR, Shin DM, Saba NF, Racial disparities in squamous cell carcinoma of the oral tongue among women: A SEER data analysis. Oral Oncol. 2015 Apr 9.

Hanasoge S, Magliocca KR, Switchenko JM, Saba NF, Wadsworth JT, El-Deiry MW, Shin DM, Khuri F, Beitler JJ, Higgins KA. Clinical outcomes in elderly patients with human papillomavirus-positive squamous cell carcinoma of the oropharynx treated with definitive chemoradiation therapy Head Neck. 2015 Apr 20

Qian G, Jiang N, Wang D, Newman S, Kim S, Chen Z, Garcia G, MacBeath G, Shin DM, Khuri FR, Chen ZG, Saba NF. Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinoma. Cancer. 2015 Jul 20.

Behera M, Pillai RN, Owonikoko TK, Kim S, Steuer C, Chen Z, Saba NF, Belani CP, Khuri FR, Ramalingam SS.Bevacizumab in Combination with Taxane versus Non-Taxane Containing Regimens for Advanced/Metastatic Nonsquamous Non-Small-Cell Lung Cancer: A Systematic Review. Thorac Oncol. 2015 Aug;10(8):1142-7.

Mohamed A, El-Rayes B, Khuri FR, Saba NF, Targeted therapies in metastatic esophageal cancer: Advances over the past decade, Critical rev in Hematology oncology Jan 2014; pii:  S1040-8428(14)00022-5.

Ernani V, Saba NF. Oral Cavity Cancer: Risk Factors, Pathology, and Management. Oncology. 2015 Jun 17

Zhang J, Saba NF, Chen GZ, Shin DM. Targeting HER (ERBB) signaling in head and neck cancer: An essential update. Mol Aspects Med. 2015 Jul 7.

Bossi P, Saba NF, Vermorken JB, Strojan P, Pala L, de Bree R, Rodrigo JP, Lopez F, Hanna EY, Haigentz M, Takes RP, Slootweg PJ, Silver CE, Rinaldo A, Ferlito A. The role of systemic therapy in the management of sinonasal cancer: A critical review. Cancer Treat Rev. 2015 Jul 31. pii: S0305-7372(15)00149-8.

Locations & Appointments

2 Office Location(s)

1

Winship Cancer Institute

Emory Clinic at 1365 Clifton Rd
1365 Clifton Rd NE
Atlanta, GA 30322
  • 404-778-1900
S
2

Emory University Hospital Midtown

550 Peachtree St NE
Glenn Bldg
Atlanta, GA 30308
  • 404-686-8189
S

2 Hospital Affiliation(s)

3

Emory University Hospital Midtown

550 Peachtree St NE
Atlanta, GA 30308
H
4

Emory University Hospital

1364 Clifton Rd NE
Atlanta, GA 30322
H

Academic Profile

Training

MEDICAL SCHOOL

American University Beirut, Beirut, Lebanon

INTERNSHIP

University of Wisconsin Hospital and Clinic, Madison, WI

RESIDENCY

Faulkner Hospital, Boston, MA

FELLOWSHIP

Brown University, Providence, RI

Princess Margaret Hospital, Toronto, ON, Canada

Professional Memberships

American Head and Neck Cancer Society

American College of Radiology (Head and Neck Panel)

American College of Physicians

American Society of Clinical Oncology

Massachusetts Medical Society

Languages spoken

  • Arabic
  • French

Major Publications

Owonikoko TK, Ramalingam SS, Miller DL, Force SD, Sica GL, Mendel J, Chen Z, Rogatko A, Tighiouart M, Harvey RD, Kim S, Saba NF, Pickens A, Behera M, Fu RW, Rossi MR, Auffermann WF, Torres WE, Bechara R, Deng X, Sun SY, Fu H, Gal AA, Khuri FR. A Translational, Pharmacodynamic, and Pharmacokinetic Phase IB Clinical Study of Everolimus in Resectable Non-Small Cell Lung Cancer; Clin Cancer Res. 2015 Apr 15;21(8):1859-68.

Steuer CE, Behera M, Kim S, Patel N, Chen Z, Pillai R, Saba NF, Shin DM, Owonikoko TK, Khuri FR, Ramalingam SS; Predictors and outcomes of venous thromboembolism in hospitalized lung cancer patients: A Nationwide Inpatient Sample database analysis. Lung Cancer. 2015 Apr;88(1):80-4.

Strojan P, Vermorken JB, Beitler JJ, Saba NF, Haigentz M, Bossi P, Worden FP, Langendijk JA, Eisbruch A, Mendenhall WM, Lee AW, Harrison LB, Bradford CR, Smee R, Silver CE, Rinaldo A, Ferlito A; Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic review; Head Neck. 2015 Mar 3.

Haque A, Rahman MA, Chen ZG, Saba NF, Khuri FR, Shin DM, Ruhul Amin AR; Combination of erlotinib and EGCG induces apoptosis of head and neck cancers through posttranscriptional regulation of Bim and Bcl-2; Apoptosis. 2015 Apr 10.

Joseph LJ, Goodman M, Higgins K, Pilai R, Ramalingam SS, Magliocca K, Patel MR, El-Deiry M, Wadsworth JT, Owonikoko TK, Beitler JJ, Khuri FR, Shin DM, Saba NF, Racial disparities in squamous cell carcinoma of the oral tongue among women: A SEER data analysis. Oral Oncol. 2015 Apr 9.

Hanasoge S, Magliocca KR, Switchenko JM, Saba NF, Wadsworth JT, El-Deiry MW, Shin DM, Khuri F, Beitler JJ, Higgins KA. Clinical outcomes in elderly patients with human papillomavirus-positive squamous cell carcinoma of the oropharynx treated with definitive chemoradiation therapy Head Neck. 2015 Apr 20

Qian G, Jiang N, Wang D, Newman S, Kim S, Chen Z, Garcia G, MacBeath G, Shin DM, Khuri FR, Chen ZG, Saba NF. Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinoma. Cancer. 2015 Jul 20.

Behera M, Pillai RN, Owonikoko TK, Kim S, Steuer C, Chen Z, Saba NF, Belani CP, Khuri FR, Ramalingam SS.Bevacizumab in Combination with Taxane versus Non-Taxane Containing Regimens for Advanced/Metastatic Nonsquamous Non-Small-Cell Lung Cancer: A Systematic Review. Thorac Oncol. 2015 Aug;10(8):1142-7.

Mohamed A, El-Rayes B, Khuri FR, Saba NF, Targeted therapies in metastatic esophageal cancer: Advances over the past decade, Critical rev in Hematology oncology Jan 2014; pii:  S1040-8428(14)00022-5.

Ernani V, Saba NF. Oral Cavity Cancer: Risk Factors, Pathology, and Management. Oncology. 2015 Jun 17

Zhang J, Saba NF, Chen GZ, Shin DM. Targeting HER (ERBB) signaling in head and neck cancer: An essential update. Mol Aspects Med. 2015 Jul 7.

Bossi P, Saba NF, Vermorken JB, Strojan P, Pala L, de Bree R, Rodrigo JP, Lopez F, Hanna EY, Haigentz M, Takes RP, Slootweg PJ, Silver CE, Rinaldo A, Ferlito A. The role of systemic therapy in the management of sinonasal cancer: A critical review. Cancer Treat Rev. 2015 Jul 31. pii: S0305-7372(15)00149-8.